Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Any Cancer Type”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04276597
What this trial is testing

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Who this might be right for
Pulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more
Excel Diagnostics and Nuclear Oncology Center
Not applicableLooking for participantsNCT06753136
What this trial is testing

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Who this might be right for
Primary Visceral Tumors of Any HistotypeVisceral LesionsLiver Cancer+9 more
Istituto Oncologico Veneto IRCCS 24
Early research (Phase 1)Study completedNCT06476548
What this trial is testing

Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors

Who this might be right for
Any Cancer Type
H. Lee Moffitt Cancer Center and Research Institute 12
Not applicableStudy completedNCT05225090
What this trial is testing

Smartphone App for Cancer Medication Adherence

Who this might be right for
CarcinomaCancer
Columbia University 100
Early research (Phase 1)Study completedNCT00698243
What this trial is testing

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Any Solid Tumor or Lymphoma
Astellas Pharma Inc 128
Not applicableNo Longer AvailableNCT06743100
What this trial is testing

18F-Floretyrosine Expanded Access Program

Who this might be right for
Glioma (Any Grade) in the Brain
Telix Pharmaceuticals (Innovations) Pty Limited
Not applicableStudy completedNCT02214134
What this trial is testing

SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access

Who this might be right for
Any Stage of Lung Cancer (Any Histotype)Any Stage of Malignant Pleural MesotheliomaAny Stage of Any Thymic Malignancy
European Organisation for Research and Treatment of Cancer - EORTC 539
Very early researchEnded earlyNCT07050836
What this trial is testing

Contrast Enhanced Ultrasound in Neurosurgery to Improve Glioma Visualization and Border Demarcation

Who this might be right for
Glioma (Any Grade) in the BrainGlioma
University of Colorado, Denver 2
Testing effectiveness (Phase 2)Looking for participantsNCT05672108
What this trial is testing

Phase II Trial of Lung Chemoemobolization

Who this might be right for
Lung Non-Small Cell CarcinomaMediastinal NeoplasmPleural Neoplasm+4 more
City of Hope Medical Center 30
Not applicableStudy completedNCT04813263
What this trial is testing

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 424
Not applicableStudy completedNCT05734053
What this trial is testing

Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 222
Testing effectiveness (Phase 2)Looking for participantsNCT05746208
What this trial is testing

Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsWell-Differentiated Neuroendocrine CarcinomaHigh Grade Neuroendocrine Carcinoma, Any Site
University of California, San Francisco 29
Not applicableStudy completedNCT01836484
What this trial is testing

Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma

Who this might be right for
Surgically Staged Endometrial and Cervical CarcinomaCervical Cancer: Invasive Disease, FIGO Stage 1B1 or HigherEndometrial Cancer+3 more
Barts & The London NHS Trust 162
Not applicableLooking for participantsNCT05415007
What this trial is testing

GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer

Who this might be right for
Cancer
Stanford University 40
Testing effectiveness (Phase 2)Study completedNCT01181271
What this trial is testing

Tandem Auto-Allo Transplant for Lymphoma

Who this might be right for
Diffuse, Large B-Cell, LymphomaLymphoma, Low-GradeT-Cell Lymphoma+4 more
Massachusetts General Hospital 42
Large-scale testing (Phase 3)Study completedNCT01650701
What this trial is testing

Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
The Lymphoma Academic Research Organisation 1,030
Not applicableActive Not RecruitingNCT07475390
What this trial is testing

99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging

Who this might be right for
Glioma (Any Grade) in the Brain
Tomsk National Research Medical Center of the Russian Academy of Sciences 40
Early research (Phase 1)Study completedNCT01099631
What this trial is testing

IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread

Who this might be right for
Cancer of the LiverLiver CancerHepatoma+2 more
Masonic Cancer Center, University of Minnesota 22
Testing effectiveness (Phase 2)Looking for participantsNCT07109323
What this trial is testing

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Who this might be right for
Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm DefinitionsCytogenetics Ultra High RiskPrimary Refractory+4 more
Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableStudy completedNCT00581698
What this trial is testing

Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 876
Next Page